Global Meglumine Market

Meglumine Comprehensive Study by Type (Diatrizoate Meglumine, Lothalamate Meglumine, Lodipamide Meglumine), Application (Cosolvent, Contrast Agent, Surfactant, Other), End Use Industry (Pharmaceuticals, Industrial, Others) Players and Region - Global Market Outlook to 2030

Meglumine Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Meglumine
The applications of meglumine in the pharmaceutical industry have been increased robustly over the past couple of decades which has ultimately generated significant demand for meglumine across the globe. This water-soluble chemical is available in white crystalline powder form which is an amino sugar derived from glucose. Meglumine is generally used in conjunction with iodinated compounds in industrial as well as pharmaceutical applications. However, several side effects associated with meglumine consumption such as restlessness, sensations of warmth, sneezing, sweating and many others. On the other hand, increasing awareness about the applications of the Meglumine will create numerous opportunities over the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Competition among existing players is due to the Meglumine Meglumine market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Meglumine Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage.The Vendors having a strong hold in the market are Merck, Tianma Microelectronics, Libang Healthcare, and Biophore India Pharmaceuticals. Analyst at AMA Research estimates that Asian Vendors will contribute the maximum growth to Global Meglumine market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck & Co. Inc. (United States), Tianma Microelectronics (China), Libang Healthcare Group (China), Shanghai New Hualian Pharmaceutical co.,ltd (China), Biophore India Pharmaceuticals Pvt Ltd (India), EstechPharma Co Ltd (South Korea), Sanofi S.A. (France) and Schering AG (Germany) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Xian Libang Pharmaceutical Co.Ltd (China), Nippi Incorporated (Japan) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Meglumine market by Type (Diatrizoate Meglumine, Lothalamate Meglumine and Lodipamide Meglumine), Application (Cosolvent, Contrast Agent, Surfactant and Other) and Region.



On the basis of geography, the market of Meglumine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use Industry, the sub-segment i.e. Pharmaceuticals will boost the Meglumine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Adoption of Meglumine in Intracellular Treatment of Leishmaniasis and Introduction to Drugs for Protozoal Infections with the Use of Meglumine

Market Growth Drivers:
Upsurging Demand for Meglumine from Pharmaceutical Applications and Provides a Safer Option for Diagnostic Testing Since it is Used as Diagnostic Agents

Challenges:
Stringent Manufacturing Mandates might Increase Production Complexities

Restraints:
Several Side Effects Associated with Some Substrates such as Restlessness, Sensations of Warmth, Sneezing, Sweating and Many Others

Opportunities:
Increasing Awareness about Meglumine Based Products from Underdeveloped Economies and Upsurging Growth of Pharmaceutical Industry with Robust R&D Investments

Market Leaders and their expansionary development strategies
In November 2021, Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging, announced a recent boom for DOTAREM, (gadoterate meglumine) injection. DOTAREM's significant increases come in the face of the continued presence of a pandemic and supply chain disruptions. The company shipped more doses of its flagship MRI contrast agent in October than in any other monthly period since its US release in 2013.
In October 2022, Fresenius Kabi announced that it has launched Gadoterate Meglumine Injection, an FDA-approved bioequivalent and therapeutic equivalent substitute for the contrast agent gadoterate meglumine (Dotarem, Guerbet).


Key Target Audience
Meglumine Manufacturers, Meglumine Distributors and Suppliers, Meglumine International Traders, Phramceutical Industry Associations, Government Agencies, Research and Developeme[nt Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Diatrizoate Meglumine
  • Lothalamate Meglumine
  • Lodipamide Meglumine
By Application
  • Cosolvent
  • Contrast Agent
  • Surfactant
  • Other
By End Use Industry
  • Pharmaceuticals
  • Industrial
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Upsurging Demand for Meglumine from Pharmaceutical Applications
      • 3.2.2. Provides a Safer Option for Diagnostic Testing Since it is Used as Diagnostic Agents
    • 3.3. Market Challenges
      • 3.3.1. Stringent Manufacturing Mandates might Increase Production Complexities
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Meglumine in Intracellular Treatment of Leishmaniasis
      • 3.4.2. Introduction to Drugs for Protozoal Infections with the Use of Meglumine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Meglumine, by Type, Application, End Use Industry and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Meglumine (Value)
      • 5.2.1. Global Meglumine by: Type (Value)
        • 5.2.1.1. Diatrizoate Meglumine
        • 5.2.1.2. Lothalamate Meglumine
        • 5.2.1.3. Lodipamide Meglumine
      • 5.2.2. Global Meglumine by: Application (Value)
        • 5.2.2.1. Cosolvent
        • 5.2.2.2. Contrast Agent
        • 5.2.2.3. Surfactant
        • 5.2.2.4. Other
      • 5.2.3. Global Meglumine by: End Use Industry (Value)
        • 5.2.3.1. Pharmaceuticals
        • 5.2.3.2. Industrial
        • 5.2.3.3. Others
      • 5.2.4. Global Meglumine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Meglumine (Volume)
      • 5.3.1. Global Meglumine by: Type (Volume)
        • 5.3.1.1. Diatrizoate Meglumine
        • 5.3.1.2. Lothalamate Meglumine
        • 5.3.1.3. Lodipamide Meglumine
      • 5.3.2. Global Meglumine by: Application (Volume)
        • 5.3.2.1. Cosolvent
        • 5.3.2.2. Contrast Agent
        • 5.3.2.3. Surfactant
        • 5.3.2.4. Other
      • 5.3.3. Global Meglumine by: End Use Industry (Volume)
        • 5.3.3.1. Pharmaceuticals
        • 5.3.3.2. Industrial
        • 5.3.3.3. Others
      • 5.3.4. Global Meglumine Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Meglumine (Price)
      • 5.4.1. Global Meglumine by: Type (Price)
  • 6. Meglumine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co. Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tianma Microelectronics (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Libang Healthcare Group (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shanghai New Hualian Pharmaceutical co.,ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biophore India Pharmaceuticals Pvt Ltd (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EstechPharma Co Ltd (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Schering AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Meglumine Sale, by Type, Application, End Use Industry and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Meglumine (Value)
      • 7.2.1. Global Meglumine by: Type (Value)
        • 7.2.1.1. Diatrizoate Meglumine
        • 7.2.1.2. Lothalamate Meglumine
        • 7.2.1.3. Lodipamide Meglumine
      • 7.2.2. Global Meglumine by: Application (Value)
        • 7.2.2.1. Cosolvent
        • 7.2.2.2. Contrast Agent
        • 7.2.2.3. Surfactant
        • 7.2.2.4. Other
      • 7.2.3. Global Meglumine by: End Use Industry (Value)
        • 7.2.3.1. Pharmaceuticals
        • 7.2.3.2. Industrial
        • 7.2.3.3. Others
      • 7.2.4. Global Meglumine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Meglumine (Volume)
      • 7.3.1. Global Meglumine by: Type (Volume)
        • 7.3.1.1. Diatrizoate Meglumine
        • 7.3.1.2. Lothalamate Meglumine
        • 7.3.1.3. Lodipamide Meglumine
      • 7.3.2. Global Meglumine by: Application (Volume)
        • 7.3.2.1. Cosolvent
        • 7.3.2.2. Contrast Agent
        • 7.3.2.3. Surfactant
        • 7.3.2.4. Other
      • 7.3.3. Global Meglumine by: End Use Industry (Volume)
        • 7.3.3.1. Pharmaceuticals
        • 7.3.3.2. Industrial
        • 7.3.3.3. Others
      • 7.3.4. Global Meglumine Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Meglumine (Price)
      • 7.4.1. Global Meglumine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Meglumine: by Type(USD Million)
  • Table 2. Meglumine Diatrizoate Meglumine , by Region USD Million (2018-2023)
  • Table 3. Meglumine Lothalamate Meglumine , by Region USD Million (2018-2023)
  • Table 4. Meglumine Lodipamide Meglumine , by Region USD Million (2018-2023)
  • Table 5. Meglumine: by Application(USD Million)
  • Table 6. Meglumine Cosolvent , by Region USD Million (2018-2023)
  • Table 7. Meglumine Contrast Agent , by Region USD Million (2018-2023)
  • Table 8. Meglumine Surfactant , by Region USD Million (2018-2023)
  • Table 9. Meglumine Other , by Region USD Million (2018-2023)
  • Table 10. Meglumine: by End Use Industry(USD Million)
  • Table 11. Meglumine Pharmaceuticals , by Region USD Million (2018-2023)
  • Table 12. Meglumine Industrial , by Region USD Million (2018-2023)
  • Table 13. Meglumine Others , by Region USD Million (2018-2023)
  • Table 14. South America Meglumine, by Country USD Million (2018-2023)
  • Table 15. South America Meglumine, by Type USD Million (2018-2023)
  • Table 16. South America Meglumine, by Application USD Million (2018-2023)
  • Table 17. South America Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 18. Brazil Meglumine, by Type USD Million (2018-2023)
  • Table 19. Brazil Meglumine, by Application USD Million (2018-2023)
  • Table 20. Brazil Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 21. Argentina Meglumine, by Type USD Million (2018-2023)
  • Table 22. Argentina Meglumine, by Application USD Million (2018-2023)
  • Table 23. Argentina Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 24. Rest of South America Meglumine, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Meglumine, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 27. Asia Pacific Meglumine, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Meglumine, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Meglumine, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 31. China Meglumine, by Type USD Million (2018-2023)
  • Table 32. China Meglumine, by Application USD Million (2018-2023)
  • Table 33. China Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 34. Japan Meglumine, by Type USD Million (2018-2023)
  • Table 35. Japan Meglumine, by Application USD Million (2018-2023)
  • Table 36. Japan Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 37. India Meglumine, by Type USD Million (2018-2023)
  • Table 38. India Meglumine, by Application USD Million (2018-2023)
  • Table 39. India Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 40. South Korea Meglumine, by Type USD Million (2018-2023)
  • Table 41. South Korea Meglumine, by Application USD Million (2018-2023)
  • Table 42. South Korea Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 43. Taiwan Meglumine, by Type USD Million (2018-2023)
  • Table 44. Taiwan Meglumine, by Application USD Million (2018-2023)
  • Table 45. Taiwan Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 46. Australia Meglumine, by Type USD Million (2018-2023)
  • Table 47. Australia Meglumine, by Application USD Million (2018-2023)
  • Table 48. Australia Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Meglumine, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Meglumine, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 52. Europe Meglumine, by Country USD Million (2018-2023)
  • Table 53. Europe Meglumine, by Type USD Million (2018-2023)
  • Table 54. Europe Meglumine, by Application USD Million (2018-2023)
  • Table 55. Europe Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 56. Germany Meglumine, by Type USD Million (2018-2023)
  • Table 57. Germany Meglumine, by Application USD Million (2018-2023)
  • Table 58. Germany Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 59. France Meglumine, by Type USD Million (2018-2023)
  • Table 60. France Meglumine, by Application USD Million (2018-2023)
  • Table 61. France Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 62. Italy Meglumine, by Type USD Million (2018-2023)
  • Table 63. Italy Meglumine, by Application USD Million (2018-2023)
  • Table 64. Italy Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 65. United Kingdom Meglumine, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Meglumine, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 68. Netherlands Meglumine, by Type USD Million (2018-2023)
  • Table 69. Netherlands Meglumine, by Application USD Million (2018-2023)
  • Table 70. Netherlands Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 71. Rest of Europe Meglumine, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Meglumine, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 74. MEA Meglumine, by Country USD Million (2018-2023)
  • Table 75. MEA Meglumine, by Type USD Million (2018-2023)
  • Table 76. MEA Meglumine, by Application USD Million (2018-2023)
  • Table 77. MEA Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 78. Middle East Meglumine, by Type USD Million (2018-2023)
  • Table 79. Middle East Meglumine, by Application USD Million (2018-2023)
  • Table 80. Middle East Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 81. Africa Meglumine, by Type USD Million (2018-2023)
  • Table 82. Africa Meglumine, by Application USD Million (2018-2023)
  • Table 83. Africa Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 84. North America Meglumine, by Country USD Million (2018-2023)
  • Table 85. North America Meglumine, by Type USD Million (2018-2023)
  • Table 86. North America Meglumine, by Application USD Million (2018-2023)
  • Table 87. North America Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 88. United States Meglumine, by Type USD Million (2018-2023)
  • Table 89. United States Meglumine, by Application USD Million (2018-2023)
  • Table 90. United States Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 91. Canada Meglumine, by Type USD Million (2018-2023)
  • Table 92. Canada Meglumine, by Application USD Million (2018-2023)
  • Table 93. Canada Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 94. Mexico Meglumine, by Type USD Million (2018-2023)
  • Table 95. Mexico Meglumine, by Application USD Million (2018-2023)
  • Table 96. Mexico Meglumine, by End Use Industry USD Million (2018-2023)
  • Table 97. Meglumine Sales: by Type(Kilogram)
  • Table 98. Meglumine Sales Diatrizoate Meglumine , by Region Kilogram (2018-2023)
  • Table 99. Meglumine Sales Lothalamate Meglumine , by Region Kilogram (2018-2023)
  • Table 100. Meglumine Sales Lodipamide Meglumine , by Region Kilogram (2018-2023)
  • Table 101. Meglumine Sales: by Application(Kilogram)
  • Table 102. Meglumine Sales Cosolvent , by Region Kilogram (2018-2023)
  • Table 103. Meglumine Sales Contrast Agent , by Region Kilogram (2018-2023)
  • Table 104. Meglumine Sales Surfactant , by Region Kilogram (2018-2023)
  • Table 105. Meglumine Sales Other , by Region Kilogram (2018-2023)
  • Table 106. Meglumine Sales: by End Use Industry(Kilogram)
  • Table 107. Meglumine Sales Pharmaceuticals , by Region Kilogram (2018-2023)
  • Table 108. Meglumine Sales Industrial , by Region Kilogram (2018-2023)
  • Table 109. Meglumine Sales Others , by Region Kilogram (2018-2023)
  • Table 110. South America Meglumine Sales, by Country Kilogram (2018-2023)
  • Table 111. South America Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 112. South America Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 113. South America Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 114. Brazil Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 115. Brazil Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 116. Brazil Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 117. Argentina Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 118. Argentina Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 119. Argentina Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 120. Rest of South America Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 121. Rest of South America Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 122. Rest of South America Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 123. Asia Pacific Meglumine Sales, by Country Kilogram (2018-2023)
  • Table 124. Asia Pacific Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 125. Asia Pacific Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 126. Asia Pacific Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 127. China Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 128. China Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 129. China Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 130. Japan Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 131. Japan Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 132. Japan Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 133. India Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 134. India Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 135. India Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 136. South Korea Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 137. South Korea Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 138. South Korea Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 139. Taiwan Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 140. Taiwan Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 141. Taiwan Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 142. Australia Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 143. Australia Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 144. Australia Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 145. Rest of Asia-Pacific Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 146. Rest of Asia-Pacific Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 147. Rest of Asia-Pacific Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 148. Europe Meglumine Sales, by Country Kilogram (2018-2023)
  • Table 149. Europe Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 150. Europe Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 151. Europe Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 152. Germany Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 153. Germany Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 154. Germany Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 155. France Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 156. France Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 157. France Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 158. Italy Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 159. Italy Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 160. Italy Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 161. United Kingdom Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 162. United Kingdom Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 163. United Kingdom Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 164. Netherlands Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 165. Netherlands Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 166. Netherlands Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 167. Rest of Europe Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 168. Rest of Europe Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 169. Rest of Europe Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 170. MEA Meglumine Sales, by Country Kilogram (2018-2023)
  • Table 171. MEA Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 172. MEA Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 173. MEA Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 174. Middle East Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 175. Middle East Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 176. Middle East Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 177. Africa Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 178. Africa Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 179. Africa Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 180. North America Meglumine Sales, by Country Kilogram (2018-2023)
  • Table 181. North America Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 182. North America Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 183. North America Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 184. United States Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 185. United States Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 186. United States Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 187. Canada Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 188. Canada Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 189. Canada Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 190. Mexico Meglumine Sales, by Type Kilogram (2018-2023)
  • Table 191. Mexico Meglumine Sales, by Application Kilogram (2018-2023)
  • Table 192. Mexico Meglumine Sales, by End Use Industry Kilogram (2018-2023)
  • Table 193. Meglumine: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Meglumine: by Type(USD Million)
  • Table 203. Meglumine Diatrizoate Meglumine , by Region USD Million (2025-2030)
  • Table 204. Meglumine Lothalamate Meglumine , by Region USD Million (2025-2030)
  • Table 205. Meglumine Lodipamide Meglumine , by Region USD Million (2025-2030)
  • Table 206. Meglumine: by Application(USD Million)
  • Table 207. Meglumine Cosolvent , by Region USD Million (2025-2030)
  • Table 208. Meglumine Contrast Agent , by Region USD Million (2025-2030)
  • Table 209. Meglumine Surfactant , by Region USD Million (2025-2030)
  • Table 210. Meglumine Other , by Region USD Million (2025-2030)
  • Table 211. Meglumine: by End Use Industry(USD Million)
  • Table 212. Meglumine Pharmaceuticals , by Region USD Million (2025-2030)
  • Table 213. Meglumine Industrial , by Region USD Million (2025-2030)
  • Table 214. Meglumine Others , by Region USD Million (2025-2030)
  • Table 215. South America Meglumine, by Country USD Million (2025-2030)
  • Table 216. South America Meglumine, by Type USD Million (2025-2030)
  • Table 217. South America Meglumine, by Application USD Million (2025-2030)
  • Table 218. South America Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 219. Brazil Meglumine, by Type USD Million (2025-2030)
  • Table 220. Brazil Meglumine, by Application USD Million (2025-2030)
  • Table 221. Brazil Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 222. Argentina Meglumine, by Type USD Million (2025-2030)
  • Table 223. Argentina Meglumine, by Application USD Million (2025-2030)
  • Table 224. Argentina Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 225. Rest of South America Meglumine, by Type USD Million (2025-2030)
  • Table 226. Rest of South America Meglumine, by Application USD Million (2025-2030)
  • Table 227. Rest of South America Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 228. Asia Pacific Meglumine, by Country USD Million (2025-2030)
  • Table 229. Asia Pacific Meglumine, by Type USD Million (2025-2030)
  • Table 230. Asia Pacific Meglumine, by Application USD Million (2025-2030)
  • Table 231. Asia Pacific Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 232. China Meglumine, by Type USD Million (2025-2030)
  • Table 233. China Meglumine, by Application USD Million (2025-2030)
  • Table 234. China Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 235. Japan Meglumine, by Type USD Million (2025-2030)
  • Table 236. Japan Meglumine, by Application USD Million (2025-2030)
  • Table 237. Japan Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 238. India Meglumine, by Type USD Million (2025-2030)
  • Table 239. India Meglumine, by Application USD Million (2025-2030)
  • Table 240. India Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 241. South Korea Meglumine, by Type USD Million (2025-2030)
  • Table 242. South Korea Meglumine, by Application USD Million (2025-2030)
  • Table 243. South Korea Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 244. Taiwan Meglumine, by Type USD Million (2025-2030)
  • Table 245. Taiwan Meglumine, by Application USD Million (2025-2030)
  • Table 246. Taiwan Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 247. Australia Meglumine, by Type USD Million (2025-2030)
  • Table 248. Australia Meglumine, by Application USD Million (2025-2030)
  • Table 249. Australia Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 250. Rest of Asia-Pacific Meglumine, by Type USD Million (2025-2030)
  • Table 251. Rest of Asia-Pacific Meglumine, by Application USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 253. Europe Meglumine, by Country USD Million (2025-2030)
  • Table 254. Europe Meglumine, by Type USD Million (2025-2030)
  • Table 255. Europe Meglumine, by Application USD Million (2025-2030)
  • Table 256. Europe Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 257. Germany Meglumine, by Type USD Million (2025-2030)
  • Table 258. Germany Meglumine, by Application USD Million (2025-2030)
  • Table 259. Germany Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 260. France Meglumine, by Type USD Million (2025-2030)
  • Table 261. France Meglumine, by Application USD Million (2025-2030)
  • Table 262. France Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 263. Italy Meglumine, by Type USD Million (2025-2030)
  • Table 264. Italy Meglumine, by Application USD Million (2025-2030)
  • Table 265. Italy Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 266. United Kingdom Meglumine, by Type USD Million (2025-2030)
  • Table 267. United Kingdom Meglumine, by Application USD Million (2025-2030)
  • Table 268. United Kingdom Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 269. Netherlands Meglumine, by Type USD Million (2025-2030)
  • Table 270. Netherlands Meglumine, by Application USD Million (2025-2030)
  • Table 271. Netherlands Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 272. Rest of Europe Meglumine, by Type USD Million (2025-2030)
  • Table 273. Rest of Europe Meglumine, by Application USD Million (2025-2030)
  • Table 274. Rest of Europe Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 275. MEA Meglumine, by Country USD Million (2025-2030)
  • Table 276. MEA Meglumine, by Type USD Million (2025-2030)
  • Table 277. MEA Meglumine, by Application USD Million (2025-2030)
  • Table 278. MEA Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 279. Middle East Meglumine, by Type USD Million (2025-2030)
  • Table 280. Middle East Meglumine, by Application USD Million (2025-2030)
  • Table 281. Middle East Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 282. Africa Meglumine, by Type USD Million (2025-2030)
  • Table 283. Africa Meglumine, by Application USD Million (2025-2030)
  • Table 284. Africa Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 285. North America Meglumine, by Country USD Million (2025-2030)
  • Table 286. North America Meglumine, by Type USD Million (2025-2030)
  • Table 287. North America Meglumine, by Application USD Million (2025-2030)
  • Table 288. North America Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 289. United States Meglumine, by Type USD Million (2025-2030)
  • Table 290. United States Meglumine, by Application USD Million (2025-2030)
  • Table 291. United States Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 292. Canada Meglumine, by Type USD Million (2025-2030)
  • Table 293. Canada Meglumine, by Application USD Million (2025-2030)
  • Table 294. Canada Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 295. Mexico Meglumine, by Type USD Million (2025-2030)
  • Table 296. Mexico Meglumine, by Application USD Million (2025-2030)
  • Table 297. Mexico Meglumine, by End Use Industry USD Million (2025-2030)
  • Table 298. Meglumine Sales: by Type(Kilogram)
  • Table 299. Meglumine Sales Diatrizoate Meglumine , by Region Kilogram (2025-2030)
  • Table 300. Meglumine Sales Lothalamate Meglumine , by Region Kilogram (2025-2030)
  • Table 301. Meglumine Sales Lodipamide Meglumine , by Region Kilogram (2025-2030)
  • Table 302. Meglumine Sales: by Application(Kilogram)
  • Table 303. Meglumine Sales Cosolvent , by Region Kilogram (2025-2030)
  • Table 304. Meglumine Sales Contrast Agent , by Region Kilogram (2025-2030)
  • Table 305. Meglumine Sales Surfactant , by Region Kilogram (2025-2030)
  • Table 306. Meglumine Sales Other , by Region Kilogram (2025-2030)
  • Table 307. Meglumine Sales: by End Use Industry(Kilogram)
  • Table 308. Meglumine Sales Pharmaceuticals , by Region Kilogram (2025-2030)
  • Table 309. Meglumine Sales Industrial , by Region Kilogram (2025-2030)
  • Table 310. Meglumine Sales Others , by Region Kilogram (2025-2030)
  • Table 311. South America Meglumine Sales, by Country Kilogram (2025-2030)
  • Table 312. South America Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 313. South America Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 314. South America Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 315. Brazil Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 316. Brazil Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 317. Brazil Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 318. Argentina Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 319. Argentina Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 320. Argentina Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 321. Rest of South America Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 322. Rest of South America Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 323. Rest of South America Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 324. Asia Pacific Meglumine Sales, by Country Kilogram (2025-2030)
  • Table 325. Asia Pacific Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 326. Asia Pacific Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 327. Asia Pacific Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 328. China Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 329. China Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 330. China Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 331. Japan Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 332. Japan Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 333. Japan Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 334. India Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 335. India Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 336. India Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 337. South Korea Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 338. South Korea Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 339. South Korea Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 340. Taiwan Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 341. Taiwan Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 342. Taiwan Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 343. Australia Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 344. Australia Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 345. Australia Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 346. Rest of Asia-Pacific Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 347. Rest of Asia-Pacific Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 348. Rest of Asia-Pacific Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 349. Europe Meglumine Sales, by Country Kilogram (2025-2030)
  • Table 350. Europe Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 351. Europe Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 352. Europe Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 353. Germany Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 354. Germany Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 355. Germany Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 356. France Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 357. France Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 358. France Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 359. Italy Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 360. Italy Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 361. Italy Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 362. United Kingdom Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 363. United Kingdom Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 364. United Kingdom Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 365. Netherlands Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 366. Netherlands Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 367. Netherlands Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 368. Rest of Europe Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 369. Rest of Europe Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 370. Rest of Europe Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 371. MEA Meglumine Sales, by Country Kilogram (2025-2030)
  • Table 372. MEA Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 373. MEA Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 374. MEA Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 375. Middle East Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 376. Middle East Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 377. Middle East Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 378. Africa Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 379. Africa Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 380. Africa Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 381. North America Meglumine Sales, by Country Kilogram (2025-2030)
  • Table 382. North America Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 383. North America Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 384. North America Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 385. United States Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 386. United States Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 387. United States Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 388. Canada Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 389. Canada Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 390. Canada Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 391. Mexico Meglumine Sales, by Type Kilogram (2025-2030)
  • Table 392. Mexico Meglumine Sales, by Application Kilogram (2025-2030)
  • Table 393. Mexico Meglumine Sales, by End Use Industry Kilogram (2025-2030)
  • Table 394. Meglumine: by Type(USD/Units)
  • Table 395. Research Programs/Design for This Report
  • Table 396. Key Data Information from Secondary Sources
  • Table 397. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Meglumine: by Type USD Million (2018-2023)
  • Figure 5. Global Meglumine: by Application USD Million (2018-2023)
  • Figure 6. Global Meglumine: by End Use Industry USD Million (2018-2023)
  • Figure 7. South America Meglumine Share (%), by Country
  • Figure 8. Asia Pacific Meglumine Share (%), by Country
  • Figure 9. Europe Meglumine Share (%), by Country
  • Figure 10. MEA Meglumine Share (%), by Country
  • Figure 11. North America Meglumine Share (%), by Country
  • Figure 12. Global Meglumine: by Type Kilogram (2018-2023)
  • Figure 13. Global Meglumine: by Application Kilogram (2018-2023)
  • Figure 14. Global Meglumine: by End Use Industry Kilogram (2018-2023)
  • Figure 15. South America Meglumine Share (%), by Country
  • Figure 16. Asia Pacific Meglumine Share (%), by Country
  • Figure 17. Europe Meglumine Share (%), by Country
  • Figure 18. MEA Meglumine Share (%), by Country
  • Figure 19. North America Meglumine Share (%), by Country
  • Figure 20. Global Meglumine: by Type USD/Units (2018-2023)
  • Figure 21. Global Meglumine share by Players 2023 (%)
  • Figure 22. Global Meglumine share by Players (Top 3) 2023(%)
  • Figure 23. Global Meglumine share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Merck & Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Merck & Co. Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Tianma Microelectronics (China) Revenue, Net Income and Gross profit
  • Figure 28. Tianma Microelectronics (China) Revenue: by Geography 2023
  • Figure 29. Libang Healthcare Group (China) Revenue, Net Income and Gross profit
  • Figure 30. Libang Healthcare Group (China) Revenue: by Geography 2023
  • Figure 31. Shanghai New Hualian Pharmaceutical co.,ltd (China) Revenue, Net Income and Gross profit
  • Figure 32. Shanghai New Hualian Pharmaceutical co.,ltd (China) Revenue: by Geography 2023
  • Figure 33. Biophore India Pharmaceuticals Pvt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 34. Biophore India Pharmaceuticals Pvt Ltd (India) Revenue: by Geography 2023
  • Figure 35. EstechPharma Co Ltd (South Korea) Revenue, Net Income and Gross profit
  • Figure 36. EstechPharma Co Ltd (South Korea) Revenue: by Geography 2023
  • Figure 37. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 38. Sanofi S.A. (France) Revenue: by Geography 2023
  • Figure 39. Schering AG (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Schering AG (Germany) Revenue: by Geography 2023
  • Figure 41. Global Meglumine: by Type USD Million (2025-2030)
  • Figure 42. Global Meglumine: by Application USD Million (2025-2030)
  • Figure 43. Global Meglumine: by End Use Industry USD Million (2025-2030)
  • Figure 44. South America Meglumine Share (%), by Country
  • Figure 45. Asia Pacific Meglumine Share (%), by Country
  • Figure 46. Europe Meglumine Share (%), by Country
  • Figure 47. MEA Meglumine Share (%), by Country
  • Figure 48. North America Meglumine Share (%), by Country
  • Figure 49. Global Meglumine: by Type Kilogram (2025-2030)
  • Figure 50. Global Meglumine: by Application Kilogram (2025-2030)
  • Figure 51. Global Meglumine: by End Use Industry Kilogram (2025-2030)
  • Figure 52. South America Meglumine Share (%), by Country
  • Figure 53. Asia Pacific Meglumine Share (%), by Country
  • Figure 54. Europe Meglumine Share (%), by Country
  • Figure 55. MEA Meglumine Share (%), by Country
  • Figure 56. North America Meglumine Share (%), by Country
  • Figure 57. Global Meglumine: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Merck & Co. Inc. (United States)
  • Tianma Microelectronics (China)
  • Libang Healthcare Group (China)
  • Shanghai New Hualian Pharmaceutical co.,ltd (China)
  • Biophore India Pharmaceuticals Pvt Ltd (India)
  • EstechPharma Co Ltd (South Korea)
  • Sanofi S.A. (France)
  • Schering AG (Germany)
Additional players considered in the study are as follows:
Xian Libang Pharmaceutical Co.Ltd (China) , Nippi Incorporated (Japan) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 224 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Meglumine Market Quantitative research analysis
Global Meglumine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck & Co. Inc. (United States), Tianma Microelectronics (China), Libang Healthcare Group (China), Shanghai New Hualian Pharmaceutical co.,ltd (China), Biophore India Pharmaceuticals Pvt Ltd (India), EstechPharma Co Ltd (South Korea), Sanofi S.A. (France) and Schering AG (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Adoption of Meglumine in Intracellular Treatment of Leishmaniasis " is seen as one of major influencing trends for Meglumine Market during projected period 2023-2030.
The Meglumine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Meglumine Market Report?

Have a Query? Click Here

Other Related Reports

Oil Line Corrosion Inhibitors Comprehensive Study by Type (Passivating, Cathodic, Precipitation inhibitors, Volatile corrosion inhibitors), Application (Process Vessels & Equipment, Storage Tanks, Pi...
$ 3450
Fiberglass Reinforced Plastics (FRP) Comprehensive Study by Type (Thermosetting, Thermoplastic), Application (Aerospace, Automotive, Marine, Construction, Other), Fiberglass (A-Glass, C-Glass, E-Glas...
$ 3350
Prepreg Carbon Fiber Comprehensive Study by Manufacturing Process (Solvent Dip Process, Hot Melt Process), Resin Type (Epoxy, Phenolic, Thermoplastic, Bismaleimide (BMI), Polyimide, Others), End-use ...
$ 3450
Detergent Polymer Comprehensive Study by Type (Polycarboxylates, Vinyl Pyrrolidone, Polyvinyl Pyrrolidone, Others), Application (Cleaners, Detergents, Soap, Personal Care Products, Others), Form (Pow...
$ 3750
Electrical Conductive Coatings Comprehensive Study by Type (Polymeric Derivatives Utilized, Conductive Filler Dispersed Varieties), Application (Consumer Electronics, Automotive Industry, Aerospace I...
$ 3750
Plastic Polymer Chemical Comprehensive Study by Application (Engineering Plastics, Commodity Plastics, Specialty Plastics), Thermoplastic Resins (Polyethylene (PE), Polypropylene (PP), Polystyrene (...
$ 3750